Considering converging evidence that CAV1/2 genes are neuroprotective and the previous association between ALS disease status and CAV1/2 enhancer regions, we hypothesised that CAV1 and CAV2 genes would be differentially expressed between ALS patients and controls within brain tissue. The gene discussed is CAV1; the disease is amyotrophic lateral sclerosis.